When hope is all that’s left

Chelsea Steyns and her son Owen are a mess of smeared icing as they arrange cupcakes for a Halloween party. Chelsea was diagnosed with inoperable brain cancer.

Photograph by: Gerry Kahrmann, PNG , Vancouver Sun

Faced with a terminal diagnosis, Chelsea Steyns decided to take extreme measures.

The family emails read like vacation postcards: jaunts to the beach, the world’s best guacamole, cool rental cars.

But the woman in the pictures is no ordinary tourist. She is 35-year-old Chelsea Steyns, a North Vancouver cancer patient.

The photos were sent from Houston, Texas, where Steyns sought treatment at a controversial clinic for a rare, inoperable brain tumour that has not responded to radiation.

The doctor to whom she turned, Dr. Stanislaw Burzyn-ski, has been branded both a dangerous quack and lauded as a life-saving saint.

This trip, and further treatment in the experimental program Steyns enrolled in, could cost up to $400,000. Her family hopes it will save her life, and the community of North Vancouver – where Chelsea, a mother of four, lives – has rallied in an effort to raise funds for this extraordinarily expensive quest.

With no further treatment options available in B.C., this is her family’s decision: would it be yours?

MEDICAL TOURISM

While an estimated 9,180 patients leave B.C. annually for medical treatment outside Canada, only a handful of those are seeking last-hope oncology care.

Medical tourism is a growing phenomenon. With easily accessible information on the Internet, many who can afford to nip across the border for hip revisions or joint replacements do so rather than join a waiting list.

Others, like Steyns, seek more experimental or unproven procedures.

Multiple sclerosis sufferers have travelled to seek “liberation therapy,” a type of balloon angioplasty that widens the jugular and azygous veins, which has yet to gain approval in Canada.

Although Canadian health authorities don’t keep statistics on patients who seek help outside the system, it is estimated that several thousand Canadian MS sufferers have travelled for this controversial treatment. (After considerable public pressure, the first Canadian study on the procedure was approved and patient recruitment began last week.)

Since 2003, Rick Baker of Timely Medical Alternatives has made a robust living as a medical broker, referring patients for treatments outside the border.

Through Baker, about 500 Canadian clients annually find their way to private hospitals in the U.S., mostly for hip and knee replacements.

Although Baker had one brain cancer client in 2006 who sought treatment at a hospital in New York state after being told he would have to wait eight months for surgery in Ontario, Baker likes to stick with “approved treatments.” For this reason, he doesn’t refer MS or oncology patients.

“I don’t want to be in a position of giving people false hope,” he said.

But for Steyns and her family, hope is everything.

TERMINAL DIAGNOSIS

Shortly after giving birth last January, Steyns, a dance teacher and mother of four, experienced temporary loss of vision and numbness on one side of her body.

After a barrage of tests, she was diagnosed with inoperable PMA, an extremely rare form of pediatric brain cancer hardly ever seen in adults.

She began a round of aggressive radiation therapy.

In August, Steyns learned the radiation had been ineffective. Her devastated family was told their only option was to begin palliative care.

They weren’t ready to accept that Chelsea would die; within a matter of days, they had heard through friends of the Burzyn-ski clinic; a quick search online brought them to his website. Steyns’ sister Emma filled out an online application, sent in a package of Steyns’ medical information, and two weeks later the sisters were on a flight to Texas.

They didn’t balk at controversy surrounding the doctor, or the cost: $35,000 up front and up to $30,000 a month for the targeted gene therapy treatment.

That doesn’t surprise Sarah Sample, patient and family counsellor at the BC Cancer Agency.

How a person handles a difficult diagnosis or prognosis is very individual, but it is common, said Sample, to want to spring into action. “Most people in the world want to do something.”

The younger a person is, the more difficult it can be to accept a terminal diagnosis. “What would drive someone as they decide on how they are going to cope would be their life stage. A young woman may be thinking I must do what I need to do to live longer for my children, for my career, for my dreams,” Sample said.

“I don’t dissuade anyone from taking extreme measures but I would want to ask them questions about the costs and benefits of something. It’s not just the cost of money, it’s the quality of life, the impact on their family, the time and energy and their caregivers’ ability to hold on.”

The BCCA doesn’t track the number of patients who seek oncology treatment outside their umbrella.

But when the doctors they employ try radical approaches, the response is swift.

TREATMENT DECISIONS

Questions about whether the BCCA is too conservative in its treatment protocols were raised earlier this year when Dr. Suresh Katakkar stepped outside of the bounds of B.C.-approved treatments in a last-ditch attempt to save the life of a terminally ill patient.

Katakkar, an American oncologist, had left his practice in Arizona to join the staff at the BCCA in 2011.

With the permission of patient Holly Hill, a 33-yearold Prince George woman with late-stage gastric cancer, Kat-akkar developed an experimental vaccine using her own cells, and gave her a chemo drug traditionally used to fight colorectal cancer.

Katakkar stated that he felt a “moral obligation” to provide this option to Hill, even if he had to step outside the cancer agency’s protocols. He was suspended by the BCCA and returned to the United States, where he continues to practice.

Although Hill died, the family remains unwavering in their support of his efforts to save her life.

“There is more leeway in the private system,” Dr. Katakkar told The Vancouver Sun. “Physicians can prescribe a lot more things even if that treatment has not yet been shown to be scientifically effective, as long as the patient can sign the consent of their own free will.

“It’s not that Health Canada is too conservative in approving drugs,” Katakkar said, there just isn’t enough freedom for doctors to try those drugs in new ways, new combinations.

Katakkar believes patients deserve more say in treatment options. “If the patient is desirous, if the quality of life is still good, they have not lost too much weight and they are not bedridden, and have gone through all conventional treatment, then yes.”

But terminal patients may be vulnerable to ambitious doctors and subject themselves to difficult and painful procedures in the process.

FEELING IN CONTROL

Dr. Chris Daugherty, an oncologist and international authority on medical ethics and end-of-life decision making at the MacLean Centre in Chicago, draws a line between patients pursuing treatments based on “real trials” and Burzynski, who he says is “off the bell-shaped curve 95 per cent of us practice on.”

Daugherty said it would be unfair to compare Burzyn-ski, whose treatments have not been shown in any randomized study to be effective, with doctors conducting clinical trials at more traditional medical centres, but in those cases Daugherty said, “Seeing patients make very difficult decisions we have to make sure we are not taking advantage of them for our own personal gain, fame or fortune. There are conflicts of interest any time research takes place.”

For Steyns and her family, finding an experimental treatment was the only option.

Her brother Dylan and sister Emma, a registered nurse, went to Texas and learned how to administer the treatment.

After several weeks in Texas, the family returned to Vancouver. Now they are working round the clock to care for her, fundraise and help her husband Todd manage their two sets of twins, Owen and Cooper, 4, and Maxine and Cash, nine months. Steyns is a fighter, and a straight shooter: “It’s a pain in the ass, really,” she said in a phone interview. “It’s not fun at all. To have to go that far away and do something so hard, it’s not an approved treatment. I’d rather be here and do something.”

She has had difficulty tolerating the treatment, and is experiencing severe side-effects including dangerously low potassium levels, temporary blindness and severe pain.

An MRI done at Lions Gate Hospital two weeks ago showed the tumour has stopped growing.

“That’s huge,” said Emma who is her sister’s primary caretaker – administering the treatment, helping with pain management and daily blood work.

“Before we went to Texas I was just sad all the time,” Emma said. “Texas really gave us a boost because the nurses and doctors are saying they’ve seen patients come in totally debilitated, as bad as Chelsea, and walk out.” That boost may be what Steyns needs.

“It’s challenging to be told that there isn’t standard treatment that will work; it’s easy to fall into despair in that context,” said Dr. Hal Gunn, co-founder of Inspire, B.C.’s integrative cancer treatment centre.

“Despair and loss of hope can be profoundly disempowering,” said Gunn. “It’s important to recognize that there is so much we don’t know about supporting health and well-being. Very occasionally, people do recover from even advanced cancer. We have to be open to the mystery of it.” Gunn said the majority of people who recover from “incurable” cancer share a range of characteristics that includes having a sense of responsibility and control in their own healing process.

COMMUNITY SUPPORT

Since going to Texas, Emma says, “We have something to focus on and work toward.”

In an extraordinary groundswell that demonstrates, perhaps, the health of the North Vancouver community in which Steyns lives, almost $200,000 has been raised through bottle drives, river-rafting trips, and car washes to support her treatment. Last Saturday, a dance gala in West Vancouver raised thousands more.

“A community coming together to raise money is an expression of love and support, and support is profoundly important to healing,” said Gunn.

Chelsea is buoyed by the gen-rosity of her supporters.

“I want to express a huge thank you to the community for all of their support. It’s totally overwhelming. I just wish I could meet them and hug them all.”

dryan@vancouversun.com

source: http://www.vancouversun.com / Home> News / by Denise Ryan, Vancouver Sun / November 10th, 2012

Algarve hosts inaugural congress on health tourism

The first international congress on health and tourism in the Algarve is being held until this Saturday (10 November) in Faro and has brought together specialists from all over the world to discuss this growing trend.

The event’s primary objective will be to promote the Algarve as a destination of excellence in the field of health and welfare.
“This initiative will reinforce the work already carried out in this area and will be the beginning of a new phase for the region, where health and wellness tourism will very soon assume importance as a destination product”, the event’s organising committee explained in a statement.
The conference will take place at the Algarve University’s Medical School and will cover a wide range of topics directed toward the link between health and tourism.
Among the speakers are international names such as: Renée-Marie Stephano (Chairman of the Medical Tourism Association), Felix Adatto of Godoi, Patricia Hernandez Ruiz, Zohra Mhamdi and Uwe Klein.
João Bacalhau, Chairman of the Administrative Board of the HPA Group, will be addressing the conference, as well as Constantine Sáclarides, João Viegas Fernandes, Teófilo Leite (Chairman of the European Association of Private Hospitals and of the Portuguese Hospitalisation Association) Paul Maló, Chitra Stern, among others.
The event has received major backing from national groups such as the HPA Group, which has several private hospitals across the region.
“We could not help but to join an initiative which is aimed at encouraging and promoting this strategic area of Tourism in the Algarve Region”, the HPA Group said.
According to the Chairman of the Organising Committee João Viegas Fernandes, not only national participants are expected but also participants from several foreign countries, including some numerous delegations as in the case of Nigeria with about thirty members.
Participants have already been confirmed from the following countries: Angola, Belgium, Brazil, Cameroon, Spain, USA, Philippines, Ghana, Gambia, Guinea-Bissau, Mexico, Nigeria, São Tome and Principe and Uganda.
For more information on the Congress or registration, contact
Débora Rêgo on mobile 962 044 291 or e-mail: debora
rego@hpalg.com

source: http://www.ThePortugalNews.com / Home> General / by TPN/ LUSA, in General / November 08th, 2012

Malaysia eyes attracting more foreigners for healthcare travel

Kuala Lumpur, Nov. 6

Malaysia is promoting its hospitals and clinics as new tourism attractions besides tropical islands, fascinating beaches and rainforest, in an effort to brand the country as a healthcare travel destination.

Malaysian Health Minister Liow Tiong Lai said on Tuesday that high-quality and reasonable rates of the country’s medical service is attracting more and more foreigner, with the number of foreign patients arrival achieved a impressive 48 percent increase to 583, 000 in 2011 compared with the previous year. The most appealing medical services is knee replacement, followed by cardiac care and cancer treatment, Liow said when opening the International Healthcare Travel Expo 2012, adding that Malaysia is “fast being recognized for the quality of its orthopedic treatment.”

Malaysian government is working to position the country as a preferable healthcare destination in the region. Liow said Malaysia Healthcare Travel Council, an agency established by the government to develop and promote the healthcare travel industry, had set up a hotline for global enquiry.

The agency has opened representative offices in Dhaka, Bangladesh and in Jakarta, Indonesia, while its Hong Kong office would be operational next year, Liow said. A medical gallery would also be set up at the Kuala Lumpur International Airport and similar facilities might be put in place at other important gateways to the country.

Liow later told a press conference that his ministry was looking at the Korea, Bangladesh, Nepal, Myanmar and China as increasing health tourists influx from these countries.

Meanwhile, Malaysia would promote traditional treatments like acupuncture from China besides modern medicine, he said.

source: http://www.NZWeek.com / Home> Business / source: Xinhua Publish / by Jane B. Hatcher / November 07th, 2012

Gallery

Kashmir to host national tourism mart in March-April

Valley’s tourism potential being showcased in WTM London Srinagar, Nov 6: Kashmir’s tourism potential is being presently showcased at the World Travel Mart in London. Tourism Department Kashmir has set up a stall at the Mart which, according to the … Continue reading →

Romania has this year approved a new state aid scheme that focuses on innovative investments

Romania has this year approved a new state aid scheme that focuses on innovative investments, in a move to boost job creation and develop the domestic R&D scene. Although companies looking to apply for state aid may perceive the process as bureaucratic, it is more streamlined than accessing EU funds, said some of the specialists that attended last week’s Access to Finance Workshop on State Aid, organized by Business Review.

The state aid schemes in place support regional development and stimulate investments, which allow companies to gain a competitive advantage, according to Oana Soviani, head of the grants and incentives practice at law firm Salans.
Aid options

There are three state aid schemes running at the moment, with one expected to close this year. Four years ago the government approved HG 1680/2008, with a total budget of EUR 1 billion. The scheme runs between 2009 and 2013 and EUR 600 million of financing is still available. It covers up to 50 percent of eligible costs and has a financing limit of EUR 28.1 million for all regions, except Bucharest and Ilfov County, where it is EUR 22.5 million.

A second scheme, HG 753/2008, had a total budget of EUR 575 million and will conclude this year.

The latest one, HG 797/2012, becomes operational in November and will run for two years. It has a maximum budget of around EUR 100 million and should finance ten projects. This one covers up to 40 percent of the costs with a financing limit of EUR 22.5 million in Bucharest and Ilfov County, and 50 percent with a limit of EUR 28.1 million for other regions.

The manufacturers of components for the automotive sector represent the largest share of recipients through the state aid scheme SAS 1680.

German firm Bosch secured EUR 39 million in state aid to develop car electrical systems and speed sensors. Draxlmaier got EUR 10 million to diversify the production of electrical cables for car manufacturers Daimler and Porsche. Meanwhile Romanian carmaker Dacia received EUR 15.4 million to develop its first SUV, the Dacia Duster, which has enjoyed lively sales. Other companies that have secured funds are active in the medical, energy and tourism sectors.

Companies wishing to get state aid need to have a solid investment plan and a good application file. Short-sighted firms may end up eventually returning the aid.

“In Romania not many applicants have flocked to get state aid, maybe due to the bureaucracy and the detailed applications that have to be made,” said Soviani of Salans. She added that EUR 600 million was still available in June as the money accessed so far has been below the initial estimates.

An investment partially funded by state aid has to be maintained for five years, which is the monitoring period. The two ongoing schemes differ in terms of investment eligibility.

For SAS 1680 the value of the project and the initial investment is taken into account, while for SAS 797 innovation is paramount, according to Soviani.

SAS 1680 has three thresholds including initial investment volumes from EUR 5 million to over EUR 30 million. Investments should create from 50 to over 300 jobs accordingly.

For SAS 797, the initial investment needs to be innovative or have an IT&C component of at least 20 percent of the investment plan. In addition it should create at least 200 jobs in the next three years following the completion of the investment.

Activities in the telecom, IT&C, informatics, R&D and manufacturing sectors would qualify automatically for this scheme, stated the Salans associate.
Eligibility costs

Companies looking to develop new units, extend existing ones or diversify production can apply for state aid, explained Soviani.

“The SAS 797 scheme focuses on innovation, while the SAS 1680 scheme covers investments that involve the asset purchasing of a closed unit, or one which would close without this acquisition,” said Soviani.

In terms of eligible costs, HG 1680 covers manufacturing units, medical and tourism buildings, as well as patents or licenses, and the full personnel expenditure for two years in the case of newly created jobs, according to Manuela Furdui, managing partner at Finexpert, a financial consultancy. The firm currently has 18 files in the approval or analysis stages for state aid. Its clients include Pirelli Tyres Romania and Lufkin Industries.

SAS 797 covers only the wage expenditure for two consecutive years of the newly created jobs. Equipment has to be new and cannot be acquired from companies within the same group, although exceptions have been made in the automotive industry, said Furdui.

The eligible costs for a production unit stand at EUR 370-EUR 425 per square meter, excluding VAT. For a tourism structure they are EUR 750, and for medical care units EUR 850.

“The land value is not included in the investment in SAS 1680, and in SAS 797 neither the building nor the land can be covered, as it is about equipment and software,” said Furdui.

Companies requesting aid under SAS 1680 need to present an investment plan and a techno-economical study. Aside from the investment plan, SAS 797 requires a job creation plan and a business plan.

The investment kicks off four months after the Ministry of Finance grants the state aid for SAS 1680, and in three months for SAS 797.

Source: business-review.ro

source: http://www.balkans.com / Home> Balkan News> Interviews / by Ovidiu Posirca, Business Review / November 05th, 2012